Hosted on MSN3mon
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600mThe move aims to enhance Merck’s capabilities in viral vector manufacturing for cell and gene therapies. MilliporeSigma specialises in developing and commercialising transfection re-agents known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback